Actively Recruiting
Influence of Air Quality on the Development and Progression of Premature Coronary Artery Disease
Led by pablo Juan-Salvadores · Updated on 2024-06-18
4272
Participants Needed
1
Research Sites
57 weeks
Total Duration
On this page
Sponsors
P
pablo Juan-Salvadores
Lead Sponsor
F
Fundacin Biomedica Galicia Sur
Collaborating Sponsor
AI-Summary
What this Trial Is About
The new global guidelines from the World Health Organization on air quality provide evidence of the damage that air pollution inflicts on human health at even lower concentrations than previously thought. Different studies have shown an increase in the incidence of coronary artery disease (CAD) in young people in recent decades. The main objective of this project is to study the impact of environmental pollutants on the premature manifestation of CAD from different epidemiological approaches and their impact on the evolution of these patients with a gender perspective. It is a retrospective analytical case-control study nested in a cohort of patients ≤40 years old with a clinical history of CAD including: ST-segment elevation myocardial infarction, non-ST-segment elevation acute coronary syndrome, unstable angina, stable angina or silent angina according to the international classification of diseases.
CONDITIONS
Official Title
Influence of Air Quality on the Development and Progression of Premature Coronary Artery Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women and men between 18 and 40 years old with a diagnosis of coronary artery disease coded in their medical records in Galicia
- Women and men between 18 and 40 years old with no diagnosis or history of coronary artery disease or other coronary disease coded in their medical records
You will not qualify if you...
- No postal code or primary care center assigned in medical records in Galicia
- Presence of non-ischemic coronary disease
- Serious condition that affects or decreases life expectancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Álvaro Cunqueiro
Vigo, Pontevedra, Spain, 36211
Actively Recruiting
Research Team
P
Pablo Juan-Salvadores, Pharma, PhD
CONTACT
V
Victor A Jiménez-Diaz, MD, MPH
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here